✦ LIBER ✦

PMH33 COST-UTILITY ANALYSIS OF DULOXETINE VERSUS VENLAFAXINE IN THE MANAGEMENT OF MAJOR DEPRESSION IN PORTUGAL

✍ Scribed by CG Pinto; A Barbosa; LS Miguel; M Feio

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH45 COST EFFECTIVENESS OF DULOXETINE C

✍ M Van Baardewijk; PM Vis; T Einarson 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PMH41 COST-UTILITY ANALYSIS OF ESCITALOP

✍ Leshno, M; Ben-Amnon, Y; Brignone, M; Marteau, F; Hansen, K 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PMH13 ASSOCIATION OF MEDICATION PERSISTE

✍ Liu, X; Tepper, P; Mullins, CD; Faries, D; Johnstone, B 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Cost effectiveness of duloxetine compare

✍ van Baardewijk, M.; Vis, P. M. J.; Einarson, T. R. 📂 Article 📅 2005 🏛 Informa plc 🌐 English ⚖ 549 KB

PMH84 PREDICTORS OFTREATMENT INITIATION

✍ W Ye; Y Zhao; R Swindle; RL Robinson 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PMH25 COST-EFFECTIVENESS OF ESCITALOPRAM

✍ N Despiégel; N Danchenko; K Maman 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB